Galaxy Surfactants Q4 Results Review: ICICI Securities Upgrades The Stock To 'Add', Hikes Target Price

Galaxy Surfactants' stronger rest of the world performance lifts Q4 Ebitda/kg, adds ICICI Securities.

Galaxy Surfactants’ revenue rose 23.2% YoY to Rs 11.5 billion aided by a realisation increase of 21.1% YoY to Rs 187/kg amid higher input cost.

(Image source: Unsplash)

Galaxy Surfactants believes volume growth would be at the lower end of its FY26 guidance of 6–8% due to challenges persisting in India; however, it has retained Ebitda/kg guidance at Rs 20.5–21.5. The company has been realigning its sales organisation structure to drive higher volumes from RoW; it hopes to grab better market share in India for better volumes.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

Galaxy Surfactants Ltd.’s Q4 FY25 Ebitda/kg showed a credible jump on better mix within specialty product on the back of stronger RoW performance and lower other expenses.

Galaxy Surfactants believes volume growth would be at the lower end of its FY26 guidance of 6–8% due to challenges persisting in India; however, it has retained Ebitda/kg guidance at Rs 20.5–21.5. The company has been realigning its sales organisation structure to drive higher volumes from RoW; it hopes to grab better market share in India for better volumes.

The worst for AMET is likely behind, and volume growth may resume from FY26.

Our EPS estimate for FY26 is now 4% lower and 2% higher for FY27. Our target price is revised to Rs 2,580 (vs Rs 2,420 earlier), valuing Galaxy Surfactants at 22x FY27E EPS (21x earlier). Upgrade rating to Add (from Hold).

Click on the attachment to read the full report:

ICICI Securities Galaxy Surfactants Q4FY25_Results_May25.pdf
Read Document

Also Read: Zydus Wellness Gets 'Buy' Upgrade From ICICI Securities On Best-In-Class Q4 Revenue Growth

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google